interferon-beta-1a + methylprednisolone

Interferon-beta-1a + methylprednisolone is a combination therapy used primarily in the management of relapsing-remitting multiple sclerosis. Interferon-beta-1a is a recombinant form of human interferon that acts as an immunomodulator, reducing inflammation and preventing nerve damage by decreasing the activity of immune cells that attack myelin in the central nervous system. Methylprednisolone is a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties, commonly used to manage acute exacerbations or relapses in multiple sclerosis. The combination has been studied as an add-on strategy to reduce relapse rates more effectively than interferon alone[4][5][2].

Brand names

Avonex

Other names

interferon beta 1aIFN beta 1aMP